Correction to: Targeted degradation of activating estrogen receptor a ligand-binding domain mutations in human breast cancer.
Gonzalez TL, Hancock M, Sun S, Gersch CL, Larios JM, David W, Hu J, Hayes DF, Wang S, Rae JM. Correction to: Targeted degradation of activating estrogen receptor a ligand-binding domain mutations in human breast cancer. Breast Cancer Res Treat. 2020 04; 180(3):623.